Aprea Therapeutics, Inc. (APRE) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRV, ADAG, ANAB, ANEB, APM, ARMP and others.
APRE has a market capitalization of $6.12M, compared to an average peer market cap of $370.02M. APRE is notably smaller than its average peer.
